BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 9060668)

  • 1. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen.
    Lin SF; Sun R; Heston L; Gradoville L; Shedd D; Haglund K; Rigsby M; Miller G
    J Virol; 1997 Apr; 71(4):3069-76. PubMed ID: 9060668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
    Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS
    Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and antigenicity of human herpesvirus 8 encoded ORF59 protein in AIDS-associated Kaposi's sarcoma.
    Katano H; Sata T; Suda T; Nakamura T; Tachikawa N; Nishizumi H; Sakurada S; Hayashi Y; Koike M; Iwamoto A; Kurata T; Mori S
    J Med Virol; 1999 Nov; 59(3):346-55. PubMed ID: 10502268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of Kaposi's sarcoma-associated herpesvirus K8.1 virion glycoprotein.
    Li M; MacKey J; Czajak SC; Desrosiers RC; Lackner AA; Jung JU
    J Virol; 1999 Feb; 73(2):1341-9. PubMed ID: 9882339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.
    Miller G; Heston L; Grogan E; Gradoville L; Rigsby M; Sun R; Shedd D; Kushnaryov VM; Grossberg S; Chang Y
    J Virol; 1997 Jan; 71(1):314-24. PubMed ID: 8985352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression.
    Sun R; Lin SF; Staskus K; Gradoville L; Grogan E; Haase A; Miller G
    J Virol; 1999 Mar; 73(3):2232-42. PubMed ID: 9971806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antibodies against viral capsid proteins of human herpesvirus 8 in AIDS-associated Kaposi's sarcoma.
    André S; Schatz O; Bogner JR; Zeichhardt H; Stöffler-Meilicke M; Jahn HU; Ullrich R; Sonntag AK; Kehm R; Haas J
    J Mol Med (Berl); 1997 Feb; 75(2):145-52. PubMed ID: 9083932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection.
    Miller G; Rigsby MO; Heston L; Grogan E; Sun R; Metroka C; Levy JA; Gao SJ; Chang Y; Moore P
    N Engl J Med; 1996 May; 334(20):1292-7. PubMed ID: 8609946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.
    Newton R; Carpenter L; Casabonne D; Beral V; Babiker A; Darbyshire J; Weller I; Weiss R; Kwan A; Bourboulia D; Munoz F; Lagos D; Boshoff C
    Br J Cancer; 2006 May; 94(10):1504-9. PubMed ID: 16705315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia.
    Qunibi W; Al-Furayh O; Almeshari K; Lin SF; Sun R; Heston L; Ross D; Rigsby M; Miller G
    Transplantation; 1998 Feb; 65(4):583-5. PubMed ID: 9500639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide.
    Davis DA; Humphrey RW; Newcomb FM; O'Brien TR; Goedert JJ; Straus SE; Yarchoan R
    J Infect Dis; 1997 May; 175(5):1071-9. PubMed ID: 9129068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia.
    Angeloni A; Heston L; Uccini S; Sirianni MC; Cottoni F; Masala MV; Cerimele D; Lin SF; Sun R; Rigsby M; Faggioni A; Miller G
    J Infect Dis; 1998 Jun; 177(6):1715-8. PubMed ID: 9607855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus.
    Glenn M; Rainbow L; Auradé F; Davison A; Schulz TF
    J Virol; 1999 Aug; 73(8):6953-63. PubMed ID: 10400794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of DNA synthesis inhibitors on Kaposi's sarcoma-associated herpesvirus cyclin and major capsid protein gene expression.
    Flore O; Gao SJ
    AIDS Res Hum Retroviruses; 1997 Sep; 13(14):1229-33. PubMed ID: 9310290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma.
    Katano H; Iwasaki T; Baba N; Terai M; Mori S; Iwamoto A; Kurata T; Sata T
    J Virol; 2000 Apr; 74(8):3478-85. PubMed ID: 10729121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.
    Sun R; Lin SF; Gradoville L; Yuan Y; Zhu F; Miller G
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10866-71. PubMed ID: 9724796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.